FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · IEX Real-Time Price · USD
4.530
+0.030 (0.67%)
Jul 22, 2024, 10:06 AM EDT - Market open
FibroBiologics Employees
FibroBiologics had 10 employees as of December 31, 2023. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change (1Y)
3
Growth (1Y)
42.86%
Revenue / Employee
n/a
Profits / Employee
-$2,253,000
Market Cap
164.31M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10 | 3 | 42.86% |
Dec 31, 2022 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
OrganiGram Holdings | 984 |
Metagenomi | 236 |
Puma Biotechnology | 185 |
Repare Therapeutics | 179 |
Rigel Pharmaceuticals | 147 |
Rani Therapeutics Holdings | 140 |
MediWound | 100 |
Syros Pharmaceuticals | 68 |
FBLG News
- 7 days ago - FibroBiologics to Present at JonesTrading Healthcare Summit 2024 - GlobeNewsWire
- 27 days ago - FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology - GlobeNewsWire
- 5 weeks ago - FibroBiologics Set to Join Russell 2000® Index - GlobeNewsWire
- 6 weeks ago - FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024 - GlobeNewsWire
- 2 months ago - FibroBiologics Announces 2024 Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - FibroBiologics Files 2024 First Quarter Report - GlobeNewsWire
- 2 months ago - FibroBiologics to Present at the BIO International Convention 2024 - GlobeNewsWire
- 3 months ago - FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office - GlobeNewsWire